Matinas BioPharma Holdings Inc (MTNB)
0.6159
+0.04
(+6.21%)
USD |
NYAM |
Nov 22, 16:00
0.5922
-0.02
(-3.85%)
After-Hours: 20:00
Matinas BioPharma Holdings Revenue (Annual): 1.096M for Dec. 31, 2023
Revenue (Annual) Chart
Historical Revenue (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.096M |
| December 31, 2022 | 3.188M |
| December 31, 2021 | 0.033M |
| December 31, 2020 | 0.1583M |
| December 31, 2019 | 0.0898M |
| Date | Value |
|---|---|
| December 31, 2018 | 0.1197M |
| December 31, 2017 | 0.1497M |
| December 31, 2016 | |
| December 31, 2015 | 0.1945M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Annual) Range, Past 5 Years
0.033M
Minimum
2021
3.188M
Maximum
2022
0.913M
Average
0.1583M
Median
2020
Revenue (Annual) Benchmarks
| Equillium Inc | 36.08M |
| Tenon Medical Inc | 2.928M |
| Alphatec Holdings Inc | 482.26M |
| Merck & Co Inc | 60.12B |
| Madrigal Pharmaceuticals Inc | -- |